Louise C. Walter

TL;DR: The updated ACS guidelines for breast cancer screening for women at average risk of breast cancer provide evidence-based recommendations and should be considered by physicians and women in discussions about breast cancer Screening.

TL;DR: This guideline update used an existing systematic evidence review of the CRC screening literature and microsimulation modeling analyses, including a new evaluation of the age to begin screening by race and sex and additional modeling that incorporates changes in US CRC incidence.

TL;DR: A framework to guide individualized cancer screening decisions in older patients may be more useful to the practicing clinician than age guidelines because it anchors decisions through quantitative estimates of life expectancy, risk of cancer death, and screening outcomes based on published data.

TL;DR: Age is a major effect modifier among patients with an eGFR of <60 ml/min per 1.73 m(2) at baseline, challenging us to move beyond a uniform stage-based approach to managing CKD.

TL;DR: Based on the results of the National Lung Screening Trial, the American Cancer Society is issuing an initial guideline for lung cancer screening as mentioned in this paper, which recommends that clinicians with access to high-volume, high-quality screening and treatment centers should initiate a discussion about screening with apparently healthy patients aged 55 years to 74 years who have at least a 30-pack-year smoking history and who currently smoke or have quit within the past 15 years.